Limitations and benefits of FDG‐PET/CT in NF1 patients with nerve sheath tumors: A cross‐sectional/longitudinal study
Autor: | Kunihiro Ikuta, Yoshihiro Nishida, Hiroshi Koike, Hiroshi Urakawa, Shiro Imagama, Kan Ito, Tomohisa Sakai, Shinji Ito |
---|---|
Rok vydání: | 2021 |
Předmět: |
Male
0301 basic medicine Cancer Research Longitudinal study Carcinogenesis Kaplan-Meier Estimate Nerve sheath Nerve Sheath Neoplasms Malignant transformation 0302 clinical medicine Positron Emission Tomography Computed Tomography Medicine Longitudinal Studies Prospective Studies Child Benignity Thyroid SUVmax General Medicine Middle Aged Prognosis Magnetic Resonance Imaging medicine.anatomical_structure Oncology natural history 030220 oncology & carcinogenesis Original Article Female Fdg pet ct Radiology Adult medicine.medical_specialty Neurofibromatosis 1 Adolescent Standardized uptake value Malignancy Young Adult 03 medical and health sciences MPNST Clinical Research Fluorodeoxyglucose F18 Humans Aged Neurofibroma Plexiform business.industry Original Articles medicine.disease PET Cross-Sectional Studies 030104 developmental biology ROC Curve Feasibility Studies business plexiform neurofibroma |
Zdroj: | Cancer Science |
ISSN: | 1349-7006 1347-9032 |
Popis: | The purposes of this study were to re‐confirm the usefulness of PET/CT in the differentiation of benignity/malignancy of neurogenic tumors in NF1 patients, and to analyze the natural course of plexiform neurofibroma (pNF) and clarify whether PET/CT is also useful for detecting tumors other than neurogenic tumors. PET/CT was prospectively imaged in 36 NF1 patients. There were 14 malignant peripheral nerve sheath tumors (MPNSTs) in 14 patients, and 54 pNFs in 30 patients. Nine patients had both MPNST and pNF. Maximal standardized uptake value (SUVmax) was significantly higher in MPNST (median 7.6: range 4.1‐10.4) (P Analyzing 68 neurogenic tumors in NF1 patients with PET/CT, SUVmax was significantly higher in MPNST compared with that of pNF, which re‐confirmed results of previous reports from other countries. In NF1 patients, plexiform neurofibroma and MPNST co‐existed, differentiation of malignancy/benignity with SUVmax of PET/CT should be carefully evaluated. PET/CT is useful to detect lesions other than neurogenic tumors such as thyroid diseases in NF1 patients. |
Databáze: | OpenAIRE |
Externí odkaz: |